Monday, October 26, 2026 | 08:56 AM ISTहिंदी में पढें
Page 29 - Bharat Biotech
Bharat Biotech to acquire GSK's Indian vaccine firm for undisclosed sum
Target company is a single-product vaccine maker with an installed capacity of 15 million doses of anti-rabies vaccine a year; revenues were Rs 180 cr last year
 "Bharat Biotech to acquire GSK's Indian vaccine firm for undisclosed sum")
Updated On : 15 Feb 2019 | 5:27 PM IST
Bharat Biotech's typhoid vaccine gets WHO pre-qualification
Typbar TCV is a result of dedicated product development at Bharat Biotech since 2001
 "Bharat Biotech's typhoid vaccine gets WHO pre-qualification")
Updated On : 03 Jan 2018 | 11:17 PM IST
Bharat Biotech's typhoid vaccine rated high in latest human trials
Vaccine is safe, 100% immunogenic, and prevents 55% of typhoid infections in the challenge trial and up to 87% infections
Updated On : 02 Oct 2017 | 5:39 PM IST